Ovarian cancer--can intraperitoneal therapy be regarded as new standard in Germany?
The German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) and the two German cooperative study groups (AGO-OVAR and NOGGO) performed a review of the currently available literature on intraperitoneal first-line treatment in advanced ovarian cancer to consider if this new option should be incorporated into the German guidelines for treatment of ovarian cancer.
du Bois
A
A
Department of Gynecology and Gynecologic Oncology, Dr Horst Schmidt Klinik (HSK) Wiesbaden, Germany. dubois@hsk-wiesbaden@uumail.de
Schmalfeldt
B
B
Meier
W
W
Sehouli
J
J
Pfisterer
J
J
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D005260:Female; D005858:Germany; D006801:Humans; D007263:Infusions, Parenteral / Q000379:methods*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017410:Practice Guidelines as Topic
D000970:Antineoplastic Agents